• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国儿童水痘发病率上升:一项年龄-时期-队列分析。

Increasing varicella incidence rates among children in the Republic of Korea: an age-period-cohort analysis.

机构信息

Department of Epidemiology,Seoul National University School of Public Health,Seoul,Republic of Korea.

Division of Pediatric Infectious Diseases,The Warren Alpert Medical School of Brown University,Providence, RI,USA.

出版信息

Epidemiol Infect. 2019 Jan;147:e245. doi: 10.1017/S0950268819001389.

DOI:10.1017/S0950268819001389
PMID:31364576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6805734/
Abstract

In the Republic of Korea, despite the introduction of one-dose universal varicella vaccination in 2005 and achieving a high coverage rate of 98.9% in 2012, the incidence rate has been increased sevenfold. This study aimed to investigate time trends of varicella incidence rate, assessing the age, period and birth cohort effects. We used national data on the annual number of reported cases from 2006 to 2017. A log-linear Poisson regression model was used to estimate age-period-cohort effects on varicella incidence rate. From 2006 to 2017, the incidence of varicella increased from 22.5 cases to more than 154.8 cases per 100 000. Peak incidence has shifted from 4 to 6 years old. The estimated period and cohort effects showed significant upward patterns, with a linear increasing trend by net drift. There has been an increase in the incidence among the Korean population regarding period and cohort despite the universal vaccination of varicella vaccine. Our data suggest the need for additional studies to address the current gap in herd immunity.

摘要

在韩国,尽管 2005 年引入了一剂通用水痘疫苗接种,并在 2012 年达到了 98.9%的高覆盖率,但发病率还是增加了七倍。本研究旨在调查水痘发病率的时间趋势,评估年龄、时期和出生队列效应。我们使用了 2006 年至 2017 年全国报告病例的年度数据。对数线性泊松回归模型用于估计水痘发病率的年龄-时期-队列效应。2006 年至 2017 年,水痘发病率从每 10 万人 22.5 例增加到 154.8 例以上。发病高峰已从 4 岁转移到 6 岁。估计的时期和队列效应显示出显著的上升模式,通过净漂移呈线性增加趋势。尽管普遍接种了水痘疫苗,但韩国人口的发病率仍呈上升趋势。我们的数据表明,需要进一步研究来解决当前群体免疫方面的差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/f4d2ebc07cef/S0950268819001389_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/1c96e90c2520/S0950268819001389_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/43be63c11915/S0950268819001389_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/039b2f5787fc/S0950268819001389_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/f4d2ebc07cef/S0950268819001389_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/1c96e90c2520/S0950268819001389_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/43be63c11915/S0950268819001389_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/039b2f5787fc/S0950268819001389_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247f/6805734/f4d2ebc07cef/S0950268819001389_fig4.jpg

相似文献

1
Increasing varicella incidence rates among children in the Republic of Korea: an age-period-cohort analysis.韩国儿童水痘发病率上升:一项年龄-时期-队列分析。
Epidemiol Infect. 2019 Jan;147:e245. doi: 10.1017/S0950268819001389.
2
Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.韩国实施十余年水痘单剂疫苗普遍接种前后(2003-2015 年)水痘和带状疱疹流行病学趋势。
Hum Vaccin Immunother. 2019;15(11):2554-2560. doi: 10.1080/21645515.2019.1603985. Epub 2019 May 7.
3
Waning Effectiveness of One-dose Universal Varicella Vaccination in Korea, 2011-2018: a Propensity Score Matched National Population Cohort.2011-2018 年韩国一剂次通用水痘疫苗效力降低:一项倾向评分匹配的全国人群队列研究。
J Korean Med Sci. 2021 Sep 13;36(36):e222. doi: 10.3346/jkms.2021.36.e222.
4
Varicella and varicella vaccination in South Korea.韩国的水痘与水痘疫苗接种
Clin Vaccine Immunol. 2014 May;21(5):762-8. doi: 10.1128/CVI.00645-13. Epub 2014 Mar 26.
5
Epidemiological Impact of the Korean National Immunization Program on Varicella Incidence.韩国国家免疫计划对水痘发病率的流行病学影响。
J Korean Med Sci. 2019 Feb 7;34(7):e53. doi: 10.3346/jkms.2019.34.e53. eCollection 2019 Feb 25.
6
Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.意大利威尼托地区常规疫苗接种对水痘流行病学的影响。
Vaccine. 2011 Nov 28;29(51):9480-7. doi: 10.1016/j.vaccine.2011.10.022. Epub 2011 Oct 19.
7
Effects of One-dose Varicella Vaccination on Disease Severity in Children during Outbreaks in Seoul, Korea.韩国首尔暴发疫情期间一剂水痘疫苗接种对儿童疾病严重程度的影响。
J Korean Med Sci. 2019 Mar 7;34(10):e83. doi: 10.3346/jkms.2019.34.e83. eCollection 2019 Mar 18.
8
Vaccination history in elementary school children enrolled in the varicella epidemic investigations held in Jeju-si, Korea in the first half of 2017.2017年上半年在韩国济州岛进行的水痘疫情调查中登记的小学生的疫苗接种史。
Epidemiol Health. 2017 Nov 13;39:e2017053. doi: 10.4178/epih.e2017053. eCollection 2017.
9
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?一剂水痘疫苗无法预防学校爆发疫情:是时候接种第二剂了吗?
Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085.
10
Epidemiology and impact of varicella vaccination: a longitudinal study 1994-2011.水痘疫苗接种的流行病学和影响:1994-2011 年的纵向研究。
Travel Med Infect Dis. 2013 Sep-Oct;11(5):310-4. doi: 10.1016/j.tmaid.2013.06.002. Epub 2013 Jun 28.

引用本文的文献

1
Worldwide Evolution of Vaccinable and Nonvaccinable Viral Skin Infections: Google Trends Analysis.可接种疫苗和不可接种疫苗的病毒性皮肤感染的全球演变:谷歌趋势分析
JMIR Dermatol. 2022 Oct 4;5(4):e35034. doi: 10.2196/35034.
2
Global varicella vaccination programs.全球水痘疫苗接种计划。
Clin Exp Pediatr. 2022 Dec;65(12):555-562. doi: 10.3345/cep.2021.01564. Epub 2022 Nov 2.
3
Seroprevalence of Varicella-Zoster Virus and Measles among Healthcare Workers in a Tertiary Medical Center in Korea.韩国一家三级医疗中心医护人员中水痘-带状疱疹病毒和麻疹的血清流行率

本文引用的文献

1
Effects of One-dose Varicella Vaccination on Disease Severity in Children during Outbreaks in Seoul, Korea.韩国首尔暴发疫情期间一剂水痘疫苗接种对儿童疾病严重程度的影响。
J Korean Med Sci. 2019 Mar 7;34(10):e83. doi: 10.3346/jkms.2019.34.e83. eCollection 2019 Mar 18.
2
Increasing Number of Scarlet Fever Cases, South Korea, 2011-2016.2011-2016 年韩国猩红热发病数增加。
Emerg Infect Dis. 2018 Jan;24(1):172-173. doi: 10.3201/eid2401.171027.
3
Effectiveness of Varicella Vaccination Program in Preventing Laboratory-Confirmed Cases in Children in Seoul, Korea.
Vaccines (Basel). 2022 Nov 18;10(11):1956. doi: 10.3390/vaccines10111956.
4
Epidemiological characteristics of varicella outbreaks in the Republic of Korea, 2016-2020.2016 - 2020年韩国水痘暴发的流行病学特征
Osong Public Health Res Perspect. 2022 Apr;13(2):133-141. doi: 10.24171/j.phrp.2022.0087. Epub 2022 Apr 26.
5
Seroprevalence comparison of different varicella vaccines among Turkish children.土耳其儿童中不同水痘疫苗的血清流行率比较
Hum Vaccin Immunother. 2022 Nov 30;18(5):2067443. doi: 10.1080/21645515.2022.2067443. Epub 2022 Apr 21.
6
The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka.比较不同水痘疫苗在土耳其儿童中的血清转化率:MAV/06 和 vOka。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4190-4193. doi: 10.1080/21645515.2021.1967037. Epub 2021 Oct 13.
7
Waning Effectiveness of One-dose Universal Varicella Vaccination in Korea, 2011-2018: a Propensity Score Matched National Population Cohort.2011-2018 年韩国一剂次通用水痘疫苗效力降低:一项倾向评分匹配的全国人群队列研究。
J Korean Med Sci. 2021 Sep 13;36(36):e222. doi: 10.3346/jkms.2021.36.e222.
8
Letter to the Editor: Effectiveness of the Varicella Vaccine in Korea: Unresolved Issues.致编辑的信:韩国水痘疫苗的有效性:未解决的问题。
J Korean Med Sci. 2021 Jul 12;36(27):e200. doi: 10.3346/jkms.2021.36.e200.
9
Infectious Respiratory Diseases Decreased during the COVID-19 Pandemic in South Korea.韩国在 COVID-19 大流行期间传染性呼吸道疾病减少。
Int J Environ Res Public Health. 2021 Jun 3;18(11):6008. doi: 10.3390/ijerph18116008.
10
Letter to the Editor: Epidemiological Comments on the Effectiveness of the Varicella Vaccine in Korea.致编辑的信:关于韩国水痘疫苗有效性的流行病学评论
J Korean Med Sci. 2020 Jul 20;35(28):e265. doi: 10.3346/jkms.2020.35.e265.
韩国首尔水痘疫苗接种计划在预防儿童实验室确诊病例方面的有效性。
J Korean Med Sci. 2016 Dec;31(12):1897-1901. doi: 10.3346/jkms.2016.31.12.1897.
4
Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.接种疫苗的韩国儿童和MAV疫苗组中水痘带状疱疹病毒血清阳性情况。
Hum Vaccin Immunother. 2016 Oct 2;12(10):2560-2564. doi: 10.1080/21645515.2016.1190056. Epub 2016 Aug 2.
5
Vaccines for postexposure prophylaxis against varicella (chickenpox) in children and adults.用于儿童和成人水痘(带状疱疹)暴露后预防的疫苗。
Paediatr Child Health. 2016 Mar;21(2):91-2. doi: 10.1093/pch/21.2.91.
6
National Infectious Diseases Surveillance data of South Korea.韩国国家传染病监测数据。
Epidemiol Health. 2014 Nov 11;36:e2014030. doi: 10.4178/epih/e2014030. eCollection 2014.
7
A web tool for age-period-cohort analysis of cancer incidence and mortality rates.一种用于癌症发病率和死亡率的年龄-时期-队列分析的网络工具。
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2296-302. doi: 10.1158/1055-9965.EPI-14-0300. Epub 2014 Aug 21.
8
Varicella and varicella vaccination in South Korea.韩国的水痘与水痘疫苗接种
Clin Vaccine Immunol. 2014 May;21(5):762-8. doi: 10.1128/CVI.00645-13. Epub 2014 Mar 26.
9
Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea.韩国国家免疫规划疫苗和非国家免疫规划疫苗覆盖情况的比较评估。
J Korean Med Sci. 2013 Sep;28(9):1283-8. doi: 10.3346/jkms.2013.28.9.1283. Epub 2013 Aug 28.
10
Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.水痘疫苗接种后的原发性和继发性失效:两剂之间间隔的影响。
Pediatr Infect Dis J. 2013 Jul;32(7):e305-13. doi: 10.1097/INF.0b013e31828b7def.